Detailed answers about MOLECULAR VISION LIMITED, including incorporation, status, business activity, and accounts information.
When was MOLECULAR VISION LIMITED founded?
MOLECULAR VISION LIMITED was officially incorporated on 24 September 2001 and is registered under company number 04292847. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is MOLECULAR VISION LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of MOLECULAR VISION LIMITED?
MOLECULAR VISION LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does MOLECULAR VISION LIMITED do?
MOLECULAR VISION LIMITED operates in the following sector: 72190 - Other research and experimental development on natural sciences and engineering. This provides insight into the company's primary business activity and industry focus.
What is MOLECULAR VISION LIMITED's registered address?
The registered office address of MOLECULAR VISION LIMITED is YORK BIOTECH CAMPUS, SAND HUTTON, YORK, ENGLAND, YO41 1LZ. This is the official address filed with Companies House for legal and statutory correspondence.
Is MOLECULAR VISION LIMITED financially stable?
The most recent accounts for MOLECULAR VISION LIMITED were made up to 30 June 2025, filed as FULL. Next accounts are due by 31 March 2027.
Does MOLECULAR VISION LIMITED have any charges or mortgages?
MOLECULAR VISION LIMITED has 2 registered charges, of which 1 is outstanding, 1 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.